| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytoplasmic Granules | 38 | 2024 | 574 | 9.070 |
Why?
|
| Protein Biosynthesis | 33 | 2020 | 2113 | 4.010 |
Why?
|
| RNA, Transfer | 11 | 2021 | 292 | 2.800 |
Why?
|
| Stress, Physiological | 22 | 2022 | 1403 | 2.590 |
Why?
|
| RNA-Binding Proteins | 27 | 2024 | 1897 | 2.560 |
Why?
|
| Ribonucleoproteins | 14 | 2020 | 372 | 2.190 |
Why?
|
| Eukaryotic Initiation Factor-2 | 18 | 2021 | 181 | 1.860 |
Why?
|
| RNA Helicases | 7 | 2024 | 144 | 1.820 |
Why?
|
| Ribonuclease, Pancreatic | 7 | 2021 | 149 | 1.790 |
Why?
|
| RNA, Messenger | 38 | 2023 | 12795 | 1.400 |
Why?
|
| RNA Processing, Post-Transcriptional | 10 | 2022 | 416 | 1.370 |
Why?
|
| G-Quadruplexes | 5 | 2023 | 143 | 1.240 |
Why?
|
| RNA | 10 | 2023 | 2726 | 1.220 |
Why?
|
| Ribosomal Proteins | 5 | 2022 | 371 | 1.200 |
Why?
|
| Gene Expression Regulation | 21 | 2021 | 11903 | 1.140 |
Why?
|
| RNA Stability | 9 | 2023 | 329 | 1.020 |
Why?
|
| Peptide Chain Initiation, Translational | 4 | 2020 | 100 | 0.980 |
Why?
|
| DNA Helicases | 6 | 2024 | 851 | 0.930 |
Why?
|
| Polyribosomes | 9 | 2020 | 109 | 0.910 |
Why?
|
| Cytoplasmic Structures | 4 | 2020 | 21 | 0.900 |
Why?
|
| Mitochondrial Proteins | 5 | 2017 | 976 | 0.870 |
Why?
|
| Organelles | 3 | 2020 | 266 | 0.790 |
Why?
|
| Eukaryotic Initiation Factor-4G | 2 | 2020 | 67 | 0.790 |
Why?
|
| RNA Interference | 9 | 2016 | 2831 | 0.770 |
Why?
|
| Poly(A)-Binding Proteins | 5 | 2011 | 35 | 0.760 |
Why?
|
| Mammals | 4 | 2020 | 1132 | 0.740 |
Why?
|
| Ribosome Subunits, Small, Eukaryotic | 2 | 2020 | 17 | 0.720 |
Why?
|
| Arsenites | 12 | 2018 | 65 | 0.700 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2008 | 4352 | 0.680 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2010 | 1974 | 0.660 |
Why?
|
| Inclusion Bodies | 3 | 2007 | 281 | 0.640 |
Why?
|
| Metered Dose Inhalers | 4 | 2006 | 25 | 0.560 |
Why?
|
| Immediate-Early Proteins | 3 | 2004 | 449 | 0.560 |
Why?
|
| Oxidative Stress | 7 | 2016 | 3113 | 0.560 |
Why?
|
| Tristetraprolin | 5 | 2008 | 38 | 0.550 |
Why?
|
| HeLa Cells | 13 | 2024 | 3093 | 0.520 |
Why?
|
| Peptide Initiation Factors | 3 | 2012 | 55 | 0.500 |
Why?
|
| Adrenergic beta-Agonists | 3 | 2009 | 345 | 0.500 |
Why?
|
| Animals | 70 | 2021 | 168459 | 0.500 |
Why?
|
| Phosphoproteins | 3 | 2020 | 2448 | 0.490 |
Why?
|
| Carrier Proteins | 8 | 2024 | 4936 | 0.490 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2016 | 2898 | 0.470 |
Why?
|
| RNA, Ribosomal | 3 | 2022 | 227 | 0.470 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2023 | 455 | 0.460 |
Why?
|
| Aerosol Propellants | 2 | 2003 | 8 | 0.450 |
Why?
|
| COS Cells | 8 | 2016 | 1130 | 0.440 |
Why?
|
| Sodium Selenite | 1 | 2012 | 11 | 0.420 |
Why?
|
| Phosphorylation | 14 | 2019 | 8320 | 0.410 |
Why?
|
| Dermatophagoides farinae | 1 | 2012 | 19 | 0.410 |
Why?
|
| alpha-Globins | 1 | 2012 | 19 | 0.410 |
Why?
|
| RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2011 | 3 | 0.400 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 750 | 0.390 |
Why?
|
| Mitochondria | 5 | 2018 | 3624 | 0.390 |
Why?
|
| Amyloid | 1 | 2016 | 841 | 0.380 |
Why?
|
| Vena Cava, Inferior | 1 | 2014 | 458 | 0.380 |
Why?
|
| Health | 1 | 2014 | 398 | 0.380 |
Why?
|
| Disease | 2 | 2014 | 672 | 0.380 |
Why?
|
| Cytokines | 9 | 2021 | 7396 | 0.360 |
Why?
|
| Cell Line | 18 | 2021 | 15601 | 0.350 |
Why?
|
| Erythroid Cells | 1 | 2012 | 238 | 0.350 |
Why?
|
| Eukaryotic Initiation Factor-4F | 4 | 2020 | 42 | 0.350 |
Why?
|
| Cell Respiration | 1 | 2010 | 201 | 0.340 |
Why?
|
| Regulon | 1 | 2010 | 71 | 0.340 |
Why?
|
| Alternative Splicing | 2 | 2020 | 1093 | 0.320 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 730 | 0.310 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2010 | 273 | 0.310 |
Why?
|
| Erythropoiesis | 1 | 2012 | 683 | 0.300 |
Why?
|
| Phase Transition | 2 | 2018 | 71 | 0.300 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2010 | 450 | 0.300 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 957 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 2022 | 7594 | 0.300 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2005 | 139 | 0.300 |
Why?
|
| Chlorofluorocarbons | 2 | 2005 | 12 | 0.290 |
Why?
|
| Eosinophilia | 1 | 2012 | 560 | 0.290 |
Why?
|
| Drug Labeling | 1 | 2009 | 248 | 0.280 |
Why?
|
| Acetylglucosamine | 1 | 2008 | 189 | 0.280 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3448 | 0.280 |
Why?
|
| Immunity, Innate | 2 | 2021 | 3065 | 0.280 |
Why?
|
| 14-3-3 Proteins | 2 | 2006 | 220 | 0.270 |
Why?
|
| Th2 Cells | 1 | 2012 | 1060 | 0.270 |
Why?
|
| Humans | 94 | 2024 | 761504 | 0.270 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 318 | 0.260 |
Why?
|
| Protein Binding | 8 | 2024 | 9351 | 0.260 |
Why?
|
| Models, Biological | 10 | 2016 | 9469 | 0.260 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2005 | 585 | 0.260 |
Why?
|
| Gene Silencing | 3 | 2007 | 1509 | 0.250 |
Why?
|
| RNA, Transfer, Met | 2 | 2002 | 14 | 0.250 |
Why?
|
| Th17 Cells | 1 | 2012 | 794 | 0.250 |
Why?
|
| Macrophages, Peritoneal | 2 | 2004 | 238 | 0.250 |
Why?
|
| Mice | 34 | 2021 | 81525 | 0.250 |
Why?
|
| Lymphocytes | 1 | 2013 | 2612 | 0.250 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 336 | 0.240 |
Why?
|
| RNA Caps | 2 | 2020 | 73 | 0.240 |
Why?
|
| Osteosarcoma | 2 | 2010 | 897 | 0.240 |
Why?
|
| 3' Untranslated Regions | 4 | 2015 | 519 | 0.240 |
Why?
|
| Guanosine Triphosphate | 2 | 2002 | 316 | 0.230 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2004 | 29 | 0.230 |
Why?
|
| Response Elements | 1 | 2006 | 309 | 0.230 |
Why?
|
| Y-Box-Binding Protein 1 | 2 | 2016 | 41 | 0.230 |
Why?
|
| Ribosomes | 3 | 2022 | 501 | 0.230 |
Why?
|
| Beclomethasone | 1 | 2003 | 38 | 0.230 |
Why?
|
| Genome | 2 | 2012 | 1740 | 0.230 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 1285 | 0.230 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2003 | 38 | 0.230 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 16981 | 0.220 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2020 | 1469 | 0.220 |
Why?
|
| Proteins | 4 | 2017 | 6032 | 0.220 |
Why?
|
| Quinones | 1 | 2003 | 78 | 0.210 |
Why?
|
| RNA, Untranslated | 2 | 2020 | 459 | 0.210 |
Why?
|
| Endoribonucleases | 3 | 2020 | 228 | 0.210 |
Why?
|
| Prions | 1 | 2004 | 180 | 0.210 |
Why?
|
| Microscopy | 1 | 2008 | 903 | 0.200 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9606 | 0.200 |
Why?
|
| Interleukin-10 | 1 | 2008 | 1175 | 0.200 |
Why?
|
| RNA, Small Interfering | 6 | 2015 | 3429 | 0.200 |
Why?
|
| Isoenzymes | 2 | 2004 | 1687 | 0.200 |
Why?
|
| eIF-2 Kinase | 3 | 2021 | 145 | 0.200 |
Why?
|
| Transfection | 5 | 2017 | 5774 | 0.200 |
Why?
|
| Albuterol | 1 | 2003 | 213 | 0.200 |
Why?
|
| Arthritis | 2 | 2004 | 680 | 0.190 |
Why?
|
| Basal Metabolism | 1 | 2002 | 161 | 0.190 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2024 | 384 | 0.190 |
Why?
|
| Cells, Cultured | 10 | 2020 | 18965 | 0.190 |
Why?
|
| Inflammation | 4 | 2010 | 10773 | 0.180 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 2244 | 0.180 |
Why?
|
| Homeostasis | 1 | 2012 | 3323 | 0.180 |
Why?
|
| Cytoplasm | 4 | 2020 | 1510 | 0.180 |
Why?
|
| Protein Phosphatase 1 | 1 | 2021 | 134 | 0.180 |
Why?
|
| Signal Transduction | 9 | 2020 | 23445 | 0.180 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 68 | 0.180 |
Why?
|
| Immunoglobulin G | 3 | 2012 | 4544 | 0.180 |
Why?
|
| Pneumonia | 1 | 2012 | 2143 | 0.180 |
Why?
|
| Sumoylation | 1 | 2020 | 83 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 4 | 2012 | 1612 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 8547 | 0.170 |
Why?
|
| Nucleic Acid Conformation | 3 | 2020 | 902 | 0.170 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2021 | 278 | 0.160 |
Why?
|
| Membrane Proteins | 4 | 2004 | 7856 | 0.160 |
Why?
|
| Muscle Cells | 1 | 2020 | 195 | 0.160 |
Why?
|
| HEK293 Cells | 3 | 2024 | 4278 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2021 | 2688 | 0.160 |
Why?
|
| Dipeptides | 2 | 2020 | 391 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2003 | 678 | 0.160 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2019 | 94 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 2226 | 0.160 |
Why?
|
| Memory, Long-Term | 1 | 2019 | 59 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1405 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 9177 | 0.150 |
Why?
|
| Base Sequence | 5 | 2016 | 12441 | 0.150 |
Why?
|
| Epoxy Compounds | 2 | 2010 | 137 | 0.150 |
Why?
|
| Anticodon | 2 | 2014 | 26 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 3792 | 0.150 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 2529 | 0.140 |
Why?
|
| Avoidance Learning | 1 | 2019 | 248 | 0.140 |
Why?
|
| Trans-Activators | 1 | 2007 | 2856 | 0.140 |
Why?
|
| Xenopus Proteins | 1 | 2020 | 434 | 0.140 |
Why?
|
| Macrolides | 2 | 2010 | 205 | 0.140 |
Why?
|
| Phenols | 1 | 2021 | 517 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1589 | 0.130 |
Why?
|
| Vinca Alkaloids | 1 | 2016 | 36 | 0.130 |
Why?
|
| Autoantigens | 2 | 2016 | 891 | 0.130 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2016 | 25 | 0.130 |
Why?
|
| Blotting, Western | 4 | 2010 | 5035 | 0.130 |
Why?
|
| Apoptosis | 6 | 2018 | 9486 | 0.130 |
Why?
|
| Microscopy, Video | 1 | 2016 | 241 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 3802 | 0.130 |
Why?
|
| Fibroblasts | 5 | 2018 | 4141 | 0.130 |
Why?
|
| Asthma | 4 | 2012 | 6234 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2024 | 4511 | 0.120 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 13446 | 0.120 |
Why?
|
| Antigens, Dermatophagoides | 2 | 2012 | 98 | 0.120 |
Why?
|
| Precipitin Tests | 3 | 2004 | 814 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2005 | 1372 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2005 | 2273 | 0.120 |
Why?
|
| Glucocorticoids | 2 | 2005 | 2161 | 0.120 |
Why?
|
| Physicians | 2 | 2011 | 4591 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 5 | 2021 | 6132 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 4016 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2017 | 247 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3076 | 0.120 |
Why?
|
| Mice, Knockout | 7 | 2016 | 14414 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2005 | 2986 | 0.120 |
Why?
|
| Benzhydryl Compounds | 1 | 2021 | 916 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 452 | 0.110 |
Why?
|
| Sodium Compounds | 3 | 2018 | 35 | 0.110 |
Why?
|
| Lung | 1 | 2012 | 10000 | 0.110 |
Why?
|
| Allergens | 2 | 2012 | 1432 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.110 |
Why?
|
| Cells | 1 | 2014 | 165 | 0.110 |
Why?
|
| Arginine | 1 | 2017 | 934 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 1971 | 0.110 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2012 | 34 | 0.100 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 2628 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 4 | 2021 | 2645 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2570 | 0.100 |
Why?
|
| Scleroderma, Systemic | 1 | 2016 | 344 | 0.100 |
Why?
|
| Autoantibodies | 2 | 2016 | 2116 | 0.100 |
Why?
|
| Teratogens | 2 | 2010 | 117 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2020 | 3162 | 0.100 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2006 | 3204 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2021 | 1841 | 0.100 |
Why?
|
| Administration, Inhalation | 2 | 2005 | 1157 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2020 | 1699 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20570 | 0.090 |
Why?
|
| Secretory Vesicles | 1 | 2012 | 128 | 0.090 |
Why?
|
| Protein Methyltransferases | 1 | 2010 | 53 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2012 | 2416 | 0.090 |
Why?
|
| Chimera | 1 | 2012 | 453 | 0.090 |
Why?
|
| Acylation | 1 | 2010 | 96 | 0.090 |
Why?
|
| Thiazoles | 2 | 2010 | 1517 | 0.090 |
Why?
|
| Tryptases | 1 | 2012 | 176 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 22169 | 0.090 |
Why?
|
| Dermatophagoides pteronyssinus | 1 | 2010 | 11 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2012 | 2909 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13639 | 0.090 |
Why?
|
| Administration, Intranasal | 1 | 2012 | 477 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2004 | 687 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
| Alprostadil | 1 | 2010 | 86 | 0.090 |
Why?
|
| Lysine | 2 | 2016 | 993 | 0.090 |
Why?
|
| Fear | 1 | 2019 | 1476 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2016 | 17635 | 0.090 |
Why?
|
| Arthritis, Experimental | 1 | 2012 | 291 | 0.080 |
Why?
|
| Protein Transport | 2 | 2006 | 1967 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2018 | 2135 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2014 | 697 | 0.080 |
Why?
|
| Macromolecular Substances | 2 | 2002 | 1434 | 0.080 |
Why?
|
| Acetyltransferases | 1 | 2010 | 231 | 0.080 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2005 | 3763 | 0.080 |
Why?
|
| Thrombin | 1 | 2012 | 591 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 6216 | 0.080 |
Why?
|
| Fibrin | 1 | 2012 | 507 | 0.080 |
Why?
|
| Equipment Design | 3 | 2006 | 3510 | 0.080 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 2141 | 0.080 |
Why?
|
| Goblet Cells | 1 | 2012 | 298 | 0.080 |
Why?
|
| Transcription Factors | 2 | 2005 | 12128 | 0.080 |
Why?
|
| Immunoglobulin E | 2 | 2012 | 1502 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 2011 | 389 | 0.080 |
Why?
|
| Mice, Transgenic | 4 | 2010 | 9539 | 0.080 |
Why?
|
| Self Disclosure | 1 | 2009 | 249 | 0.080 |
Why?
|
| Macrophages | 4 | 2008 | 5769 | 0.080 |
Why?
|
| Cell Survival | 5 | 2018 | 5791 | 0.080 |
Why?
|
| Fibrinogen | 1 | 2012 | 888 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2016 | 3968 | 0.080 |
Why?
|
| Heat-Shock Response | 1 | 2009 | 179 | 0.070 |
Why?
|
| Methylation | 1 | 2010 | 1084 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2006 | 2206 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 256 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 390 | 0.070 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2007 | 46 | 0.070 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 662 | 0.070 |
Why?
|
| Dust | 1 | 2010 | 487 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2009 | 1080 | 0.070 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 1749 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2017 | 3597 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 367 | 0.070 |
Why?
|
| Yeasts | 1 | 2007 | 279 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3778 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2007 | 214 | 0.060 |
Why?
|
| Killer Cells, Natural | 2 | 2006 | 2200 | 0.060 |
Why?
|
| Blood Coagulation | 1 | 2012 | 1154 | 0.060 |
Why?
|
| Alphavirus | 1 | 2005 | 10 | 0.060 |
Why?
|
| Powders | 1 | 2005 | 80 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 22170 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 2469 | 0.060 |
Why?
|
| bcl-X Protein | 2 | 2004 | 410 | 0.060 |
Why?
|
| Pharmacokinetics | 1 | 2005 | 86 | 0.060 |
Why?
|
| Constipation | 1 | 2010 | 563 | 0.060 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 980 | 0.060 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2006 | 329 | 0.060 |
Why?
|
| Drug Design | 1 | 2010 | 1048 | 0.060 |
Why?
|
| Ceramics | 1 | 2005 | 113 | 0.060 |
Why?
|
| Cataract | 1 | 2011 | 832 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 2007 | 1606 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6534 | 0.060 |
Why?
|
| Spinal Fractures | 1 | 2011 | 705 | 0.060 |
Why?
|
| Mast Cells | 1 | 2012 | 1392 | 0.060 |
Why?
|
| Cyclooxygenase 2 | 2 | 2004 | 597 | 0.060 |
Why?
|
| Cell Extracts | 1 | 2004 | 135 | 0.060 |
Why?
|
| Heparin | 1 | 2012 | 1634 | 0.060 |
Why?
|
| Cell Fractionation | 1 | 2004 | 251 | 0.060 |
Why?
|
| Mutation | 6 | 2017 | 30052 | 0.060 |
Why?
|
| Sjogren's Syndrome | 1 | 2006 | 237 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2011 | 1530 | 0.060 |
Why?
|
| Uridine | 1 | 2004 | 141 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2008 | 1201 | 0.050 |
Why?
|
| Gene Knockout Techniques | 2 | 2017 | 802 | 0.050 |
Why?
|
| Anti-Asthmatic Agents | 2 | 2005 | 574 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 532 | 0.050 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2005 | 783 | 0.050 |
Why?
|
| Life Expectancy | 1 | 2010 | 1242 | 0.050 |
Why?
|
| Sendai virus | 1 | 2002 | 22 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2005 | 720 | 0.050 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2002 | 37 | 0.050 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 2002 | 32 | 0.050 |
Why?
|
| Heme | 1 | 2005 | 313 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 439 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2016 | 2665 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 1091 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4575 | 0.050 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 695 | 0.050 |
Why?
|
| Benzoquinones | 1 | 2003 | 198 | 0.050 |
Why?
|
| Kinetics | 1 | 2010 | 6374 | 0.050 |
Why?
|
| Bronchodilator Agents | 1 | 2006 | 512 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 397 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 390 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 17904 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 365 | 0.050 |
Why?
|
| Osteoblasts | 2 | 2018 | 1143 | 0.050 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2002 | 299 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2005 | 943 | 0.050 |
Why?
|
| Environment | 1 | 2008 | 1123 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2004 | 513 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2004 | 624 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 1972 | 0.050 |
Why?
|
| Neutrophils | 2 | 2004 | 3767 | 0.050 |
Why?
|
| Particle Size | 1 | 2005 | 1648 | 0.050 |
Why?
|
| Glaucoma | 1 | 2011 | 1185 | 0.050 |
Why?
|
| Lactams, Macrocyclic | 1 | 2003 | 318 | 0.050 |
Why?
|
| Automation, Laboratory | 1 | 2021 | 102 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 1664 | 0.050 |
Why?
|
| Aerosols | 1 | 2003 | 635 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2017 | 1791 | 0.050 |
Why?
|
| Hematopoiesis | 1 | 2010 | 2049 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1809 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3734 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2005 | 1395 | 0.040 |
Why?
|
| Myocardium | 2 | 2015 | 4726 | 0.040 |
Why?
|
| Serine | 1 | 2004 | 830 | 0.040 |
Why?
|
| Cell Movement | 1 | 2012 | 5203 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 2020 | 384 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2180 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 3612 | 0.040 |
Why?
|
| Angiomyolipoma | 1 | 2021 | 187 | 0.040 |
Why?
|
| Biophysical Phenomena | 1 | 2020 | 320 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2020 | 183 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 3712 | 0.040 |
Why?
|
| Molsidomine | 1 | 2018 | 22 | 0.040 |
Why?
|
| Adenosine | 1 | 2004 | 808 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2003 | 1248 | 0.040 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2021 | 201 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 341 | 0.040 |
Why?
|
| Olfactory Perception | 1 | 2019 | 65 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 1171 | 0.040 |
Why?
|
| Male | 12 | 2021 | 360804 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2003 | 1638 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2018 | 50 | 0.040 |
Why?
|
| Nitric Oxide Donors | 1 | 2018 | 125 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 1022 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2023 | 2496 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 259 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 711 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2006 | 10766 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.040 |
Why?
|
| RNA, Viral | 2 | 2005 | 2846 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2020 | 1762 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2005 | 2767 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2422 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2002 | 918 | 0.040 |
Why?
|
| Biological Products | 1 | 2006 | 914 | 0.040 |
Why?
|
| Endocytosis | 1 | 2021 | 957 | 0.040 |
Why?
|
| Janus Kinase 2 | 1 | 2020 | 560 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1486 | 0.030 |
Why?
|
| Time Factors | 5 | 2017 | 39967 | 0.030 |
Why?
|
| Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
| Ribonucleases | 1 | 2017 | 277 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 1456 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 147 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2021 | 1251 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 934 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2016 | 200 | 0.030 |
Why?
|
| Polyribonucleotide Nucleotidyltransferase | 1 | 2015 | 6 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2015 | 47 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2005 | 1909 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2016 | 427 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2021 | 5869 | 0.030 |
Why?
|
| Binding Sites | 1 | 2004 | 6055 | 0.030 |
Why?
|
| Muscles | 1 | 2020 | 1576 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2005 | 3688 | 0.030 |
Why?
|
| Phenotype | 2 | 2021 | 16591 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 8002 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2015 | 153 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2872 | 0.030 |
Why?
|
| Vincristine | 1 | 2016 | 1036 | 0.030 |
Why?
|
| Gene Expression | 2 | 2003 | 7581 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1784 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 11076 | 0.030 |
Why?
|
| Hypertonic Solutions | 1 | 2012 | 82 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2003 | 3208 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5486 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 18252 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 732 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 1989 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2002 | 3442 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7407 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1712 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2015 | 666 | 0.020 |
Why?
|
| Crystallins | 1 | 2011 | 75 | 0.020 |
Why?
|
| Middle Aged | 5 | 2020 | 220895 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 5789 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2012 | 817 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2020 | 3688 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2803 | 0.020 |
Why?
|
| Hypospadias | 1 | 2011 | 97 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1469 | 0.020 |
Why?
|
| Caspases | 2 | 2003 | 879 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2002 | 2155 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2017 | 1787 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2011 | 259 | 0.020 |
Why?
|
| Carcinogens | 1 | 2012 | 452 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 1349 | 0.020 |
Why?
|
| United States | 2 | 2009 | 72334 | 0.020 |
Why?
|
| Organogenesis | 1 | 2011 | 215 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.020 |
Why?
|
| Female | 8 | 2020 | 392644 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 982 | 0.020 |
Why?
|
| Chloride Channels | 1 | 2010 | 221 | 0.020 |
Why?
|
| Edema | 1 | 2012 | 766 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2006 | 67 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3849 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2006 | 66 | 0.020 |
Why?
|
| Hippocampus | 1 | 2019 | 3766 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 432 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 721 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5439 | 0.020 |
Why?
|
| Inhalation Spacers | 1 | 2005 | 4 | 0.020 |
Why?
|
| DNA Damage | 2 | 2007 | 2446 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2005 | 203 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10552 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 59243 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 231 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2012 | 757 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2020 | 4652 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 4249 | 0.010 |
Why?
|
| Macrophages, Alveolar | 1 | 2006 | 412 | 0.010 |
Why?
|
| Cholinergic Antagonists | 1 | 2005 | 168 | 0.010 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2003 | 10 | 0.010 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 88 | 0.010 |
Why?
|
| Adult | 4 | 2020 | 221177 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2010 | 1475 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1529 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 64680 | 0.010 |
Why?
|
| Respirovirus Infections | 1 | 2002 | 52 | 0.010 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2002 | 106 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 1351 | 0.010 |
Why?
|
| Granzymes | 1 | 2003 | 277 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2006 | 1596 | 0.010 |
Why?
|
| Serpins | 1 | 2003 | 247 | 0.010 |
Why?
|
| Cell Count | 1 | 2006 | 1835 | 0.010 |
Why?
|
| Aged | 3 | 2020 | 169289 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1023 | 0.010 |
Why?
|
| Orthopedic Procedures | 1 | 2011 | 1265 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 740 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10445 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 1410 | 0.010 |
Why?
|
| Skin | 1 | 2012 | 4484 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36192 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4174 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2538 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5722 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20098 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 7529 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 10209 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 7390 | 0.000 |
Why?
|